Inhaltsbereich
| 226 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 10 / 12
 Druckansicht
|
| Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives. |
| Tiefenbacher A, Pirker R |
| Memo. 2018 May 18. doi: 10.1007/s12254-018-0408-y. pii: 408. pmc: PMC6006273 |
| PMID: 29983826 |
| Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. |
| Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Zhao Y, Yu H, Zhao Y, Chen W, Luo Y, Wu L, Wang X, Pirker R, Nan K, Jin F, Dong J, Li B, Sun Y |
| JAMA oncology. 2018 Aug 9. pii: 2696341. doi: 10.1001/jamaoncol.2018.3039 |
| PMID: 30098152 |
| Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| Pirker R |
| ESMO open. 2018 Aug 10. doi: 10.1136/esmoopen-2018-000421. pii: esmoopen-2018-000421. pmc: PMC6088342 |
| PMID: 30116594 |
| Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe. |
| Vrdoljak E, Bodoky G, Jassem J, Popescu R, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kopečková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Sikic B |
| The oncologist. 2018 Sep 4. pii: theoncologist.2018-0093. doi: 10.1634/theoncologist.2018-0093 |
| PMID: 30181313 |
| PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma. |
| Zaric B, Brcic L, Buder A, Brandstetter A, Buresch JO, Traint S, Kovacevic T, Stojsic V, Perin B, Pirker R, Filipits M |
| Clinical lung cancer. 2018 Aug 22. pii: S1525-7304(18)30208-0. doi: 10.1016/j.cllc.2018.08.014 |
| PMID: 30197262 |
| Treatment of Advanced Non-Small-Cell Lung Cancer: From Chemotherapy to Chemoimmunotherapy. |
| Pirker R |
| Journal of oncology practice. doi: 10.1200/JOP.18.00474 |
| PMID: 30205773 |
| The role of ethnic tourism in the food knowledge tradition of Tyrolean migrants in Treze Tílias, SC, Brazil. |
| Kuhn E, Haselmair R, Pirker H, Vogl CR |
| Journal of ethnobiology and ethnomedicine. 2018 Apr 6. doi: 10.1186/s13002-018-0224-9. pii: 10.1186/s13002-018-0224-9. pmc: PMC5889527 |
| PMID: 29625616 |
| Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives. |
| Pirker R, Filipits M |
| Clinical lung cancer. 2018 Sep 24. pii: S1525-7304(18)30261-4. doi: 10.1016/j.cllc.2018.09.016 |
| PMID: 30309777 |
| Management of stage IA -mutant adenocarcinoma of the lung. |
| Pirker R |
| Journal of thoracic disease. doi: 10.21037/jtd.2018.08.70. pii: jtd-10-S26-S3260. pmc: PMC6186648 |
| PMID: 30370132 |
| LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer. |
| Seymour L, Le Teuff G, Brambilla E, Shepherd FA, Soria JC, Kratzke R, Graziano S, Douillard JY, Rosell R, Reiman A, Lacas B, Lueza B, Aviel-Ronen S, McLeer A, Le Chevalier T, Pirker R, Filipits M, Dunant A, Pignon JP, Tsao MS |
| Clinical lung cancer. 2018 Oct 11. pii: S1525-7304(18)30262-6. doi: 10.1016/j.cllc.2018.10.001 |
| PMID: 30414783 |
| Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer. |
| Pirker R |
| Current opinion in oncology. 2018 Nov 9. doi: 10.1097/CCO.0000000000000496 |
| PMID: 30418192 |
| EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR. |
| Buder A, Setinek U, Hochmair MJ, Schwab S, Kirchbacher K, Keck A, Burghuber OC, Pirker R, Filipits M |
| Targeted oncology. 2019 Feb 27. doi: 10.1007/s11523-019-00623-x. pii: 10.1007/s11523-019-00623-x |
| PMID: 30810887 |
| Systemic therapy of elderly patients with advanced non-small cell lung cancer-individualized treatment is key. |
| Pirker R |
| Annals of translational medicine. doi: 10.21037/atm.2019.03.10. pii: atm-07-S1-S48. pmc: PMC6462625 |
| PMID: 31032327 |
| From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer. |
| Pirker R, Filipits M |
| ESMO open. 2019 Sep 8. doi: 10.1136/esmoopen-2019-000548. pii: esmoopen-2019-000548. pmc: PMC6735665 |
| PMID: 31555485 |
| Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer. |
| Pirker R |
| Current opinion in oncology. 2019 Oct 9. doi: 10.1097/CCO.0000000000000592 |
| PMID: 31599771 |
| Individualizing treatment of nonsmall cell lung cancer. |
| Pirker R |
| Current opinion in oncology. 2019 Oct 24. doi: 10.1097/CCO.0000000000000597 |
| PMID: 31652144 |
| Presurgical epilepsy evaluation and epilepsy surgery. |
| Baumgartner C, Koren JP, Britto-Arias M, Zoche L, Pirker S |
| F1000Research. 2019 Oct 29. doi: 10.12688/f1000research.17714.1. pmc: PMC6820825 |
| PMID: 31700611 |
| Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer. |
| Voigt W, Manegold C, Pilz L, Wu YL, Müllauer L, Pirker R, Filipits M, Niklinski J, Petruzelka L, Prosch H |
| Current opinion in oncology. 2019 Nov 9. doi: 10.1097/CCO.0000000000000598 |
| PMID: 31714259 |
| Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses. |
| Pierceall WE, Olaussen KA, Rousseau V, Brambilla E, Sprott KM, Andre F, Pignon JP, Le Chevalier T, Pirker R, Jiang C, Filipits M, Chen Y, Kutok JL, Weaver DT, Ward BE, Soria JC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)35194-4. doi: 10.1093/annonc/mdr624 |
| PMID: 32018692 |
| Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. |
| Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)34677-0. doi: 10.1093/annonc/mdr381 |
| PMID: 32018580 |
| 226 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 10 / 12
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
